Search bioRxiv⌕ Search

Biology subjects

Kuijjer, M. L.

Publications and source records attributed to Kuijjer, M. L..

33 records · Page 2Linked to original sources

rPanglaoDB: an R package to download and merge labeled single-cell RNA-seq data from the PanglaoDB database

MotivationCharacterizing cells with rare molecular phenotypes is one of the promises of high throughput single-cell RNA sequencing (scRNA-seq) techniques. However, collecting enough cells with the desired molecular phenotype in a single experiment is challenging, requiring several samples preprocessing steps to filter and collect the desired cells experimentally before sequencing. Data integration of multiple public single-cell experiments stands as a solution for this problem, allowing the collection of enough cells exhibiting the desired molecular signatures. By increasing the sample size of the desired cell type, this approach enables a robust cell type transcriptome characterization. ResultsHere, we introduce rPanglaoDB, an R package to download and merge the uniformly processed and annotated scRNA-seq data provided by the PanglaoDB database. To show the potential of rPanglaoDB for collecting rare cell types by integrating multiple public datasets, we present a biological application collecting and characterizing a set of 157 fibrocytes. Fibrocytes are a rare monocyte-derived cell type, that exhibits both the inflammatory features of macrophages and the tissue remodeling properties of fibroblasts. This constitutes the first fibrocytes unbiased transcriptome profile report. We compared the transcriptomic profile of the fibrocytes against the fibroblasts collected from the same tissue samples and confirm their associated relationship with healing processes in tissue damage and infection through the activation of the prostaglandin biosynthesis and regulation pathway. Availability and ImplementationrPanglaoDB is implemented as an R package available through the CRAN repositories https://CRAN.R-project.org/package=rPanglaoDB. Contactdaniecos@uio.no Supplementary informationCode to replicate the case example and figure 1 is available at https://github.com/dosorio/rPanglaoDB O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=161 SRC="FIGDIR/small/446161v1_fig1.gif" ALT="Figure 1"> View larger version (44K): org.highwire.dtl.DTLVardef@b4e67forg.highwire.dtl.DTLVardef@88a46aorg.highwire.dtl.DTLVardef@e25681org.highwire.dtl.DTLVardef@19d5bb7_HPS_FORMAT_FIGEXP M_FIG O_FLOATNOFigure 1.C_FLOATNO Characterization of the fibrocytes transcriptome. (A) Identification of cells expressing marker genes that differentiate fibrocytes identity from macrophages and fibroblasts (CD34, ACTA2, FN1, Collagen V, FAP and SIRPA). (B) Cross validation of the identified cells expressing CD34+, ACTA2+, COL5A1+, COL5A2+, COL5A3+, FN1+, FAP+, SIRPA+, PTPRC+, MME+, and SEMA7A+ by kernel density estimation through the Nebulosa package. (C) Volcano plot displaying the differential expression between fibrocytes and the fibroblasts collected in the same merged samples. (D) Enrichment of the prostaglandin biosynthesis and regulation pathway using GSEA through the fgsea package. (E) Enrichment of the prostaglandin biosynthesis and regulation pathway using ssGSEA through the GSVA package. C_FIG

bioinformatics↗

Adjustment of spurious correlations in co-expression measurements from RNA-Sequencing data

1Gene co-expression measurements are widely used in computational biology to identify coordinated expression patterns across a group of samples, which may indicate that these genes are controlled by the same transcriptional regulatory program, or involved in common biological processes. Gene co-expression is generally estimated from RNA-Sequencing data, which are commonly normalized to remove technical variability. Here, we demonstrate that certain normalization methods, in particular quantile-based methods, can introduce false-positive associations between genes, and that this can consequently hamper downstream co-expression network analysis. Quantile-based normalization can, however, be extremely powerful. In particular when preprocessing large-scale heterogeneous data, quantile-based normalization methods such as smooth quantile normalization can be applied to remove technical variability while maintaining global differences in expression for samples with different biological attributes. We therefore developed SNAIL, a normalization method based on smooth quantile normalization specifically designed for modeling of co-expression measurements. We show that SNAIL avoids formation of false-positive associations in co-expression as well as in downstream network analyses. Using SNAIL, one can avoid arbitrary gene filtering and retain associations to genes that only express in small subgroups of samples. This highlights the methods potential future impact on network modeling and other association-based approaches in large-scale heterogeneous data.

bioinformatics↗

immuneML: an ecosystem for machine learning analysis of adaptive immune receptor repertoires

Adaptive immune receptor repertoires (AIRR) are key targets for biomedical research as they record past and ongoing adaptive immune responses. The capacity of machine learning (ML) to identify complex discriminative sequence patterns renders it an ideal approach for AIRR-based diagnostic and therapeutic discovery. To date, widespread adoption of AIRR ML has been inhibited by a lack of reproducibility, transparency, and interoperability. immuneML (immuneml.uio.no) addresses these concerns by implementing each step of the AIRR ML process in an extensible, open-source software ecosystem that is based on fully specified and shareable workflows. To facilitate widespread user adoption, immuneML is available as a command-line tool and through an intuitive Galaxy web interface, and extensive documentation of workflows is provided. We demonstrate the broad applicability of immuneML by (i) reproducing a large-scale study on immune state prediction, (ii) developing, integrating, and applying a novel method for antigen specificity prediction, and (iii) showcasing streamlined interpretability-focused benchmarking of AIRR ML.

bioinformatics↗

Regulation of PD1 signaling is associated with prognosis in glioblastoma multiforme

Glioblastoma is an aggressive cancer of the brain and spine. While analysis of glioblastoma omics data has somewhat improved our understanding of the disease, it has not led to direct improvement in patient survival. Cancer survival is often characterized by differences in expression of particular genes, but the mechanisms that drive these differences are generally unknown. We therefore set out to model the regulatory mechanisms that associate with glioblastoma survival. We inferred individual patient gene regulatory networks using data from two different expression platforms from The Cancer Genome Atlas (n=522 and 431). We performed a comparative network analysis between patients with long- and short-term survival, correcting for patient age, sex, and neoadjuvant treatment status. We identified seven pathways associated with survival, all of which were involved in immune system signaling. Differential regulation of PD1 signaling was validated in an independent dataset from the German Glioma Network (n=70). We found that transcriptional repression of genes in this pathway--for which treatment options are available--was lost in short-term survivors and that this was independent of mutation burden and only weakly associated with T-cell infiltrate. These results provide a new way to stratify glioblastoma patients that uses network features as biomarkers to predict survival, and identify new potential therapeutic interventions, thus underscoring the value of analyzing gene regulatory networks in individual cancer patients.

systems biology↗

Identification of key tissue-specific, biological processes by integrating enhancer information in maize gene regulatory networks

Enhancers are important regulators of gene expression during numerous crucial processes including tissue differentiation across development. In plants, their recent molecular characterization revealed their capacity to activate the expression of several target genes through the binding of transcription factors. Nevertheless, identifying these target genes at a genome-wide level remains a challenge, in particular in species with large genomes, where enhancers and target genes can be hundreds of kilobases away. Therefore, the contribution of enhancers to regulatory network is still poorly understood in plants. In this study, we investigate the enhancer-driven regulatory network of two maize tissues at different stages: leaves at seedling stage and husks (bracts) at flowering. Using a systems biology approach, we integrate genomic, epigenomic and transcriptomic data to model the regulatory relationship between transcription factors and their potential target genes. We identify regulatory modules specific to husk and V2-IST, and show that they are involved in distinct functions related to the biology of each tissue. We evidence enhancers exhibiting binding sites for two distinct transcription factor families (DOF and AP2/ERF) that drive the tissue-specificity of gene expression in seedling immature leaf and husk. Analysis of the corresponding enhancer sequences reveals that two different transposable element families (TIR transposon Mutator and MITE Pif/Harbinger) have shaped the regulatory network in each tissue, and that MITEs have provided new transcription factor binding sites that are involved in husk tissue-specificity.Significance Enhancers play a major role in regulating tissue-specific gene expression in higher eukaryotes, including angiosperms. While molecular characterization of enhancers has improved over the past years, identifying their target genes at the genome-wide scale remains challenging. Here, we integrate genomic, epigenomic and transcriptomic data to decipher the tissue-specific gene regulatory network controlled by enhancers at two different stages of maize leaf development. Using a systems biology approach, we identify transcription factor families regulating gene tissue-specific expression in husk and seedling leaves, and characterize the enhancers likely to be involved. We show that a large part of maize enhancers is derived from transposable elements, which can provide novel transcription factor binding sites crucial to the regulation of tissue-specific biological functions.Competing Interest StatementThe authors have declared no competing interest.View Full Text

systems biology↗

PUMA: PANDA Using MicroRNA Associations

Conventional methods to analyze genomic data do not make use of the interplay between multiple factors, such as between microRNAs (miRNAs) and the mRNA transcripts they regulate, and thereby often fail to identify the cellular processes that are unique to specific tissues. We developed PUMA (PANDA Using MicroRNA Associations), a computational tool that uses message passing to integrate a prior network of miRNA target predictions with protein-protein interaction and target gene co-expression information to model genome-wide gene regulation by miRNAs. We applied PUMA to 38 tissues from the Genotype-Tissue Expression (GTEx) project, integrating RNA-Seq data with two different miRNA target predictions priors, built on predictions from TargetScan and miRanda, respectively. We found that while target predictions obtained from these two different resources are considerably different, PUMA captures similar tissue-specific miRNA-target gene regulatory interactions in the different network models. Furthermore, tissue-specific functions of miRNAs, which we identified by analyzing their regulatory profiles and which we made available through a Shiny app (https://kuijjer.shinyapps.io/puma_gtex/), are highly similar between networks modeled on the two target prediction resources. This indicates that PUMA consistently captures important tissue-specific regulatory processes of miRNAs. In addition, using PUMA we identified miRNAs regulating important tissue-specific processes that, when mutated, may result in disease development in the same tissue. PUMA is available in C++, MATLAB, and Python code on GitHub (https://github.com/kuijjerlab/PUMA and https://github.com/kuijjerlab/PyPuma).

systems biology↗

lionessR: single-sample network reconstruction in R

We recently developed LIONESS (Linear Interpolation to Obtain Network Estimates for Single Samples), a method that can be used together with network reconstruction algorithms to extract networks for individual samples in a population. LIONESS was originally made available as a function within the PANDA (Passing Attributes between Networks for Data Assimilation) regulatory network reconstruction framework. In this application note, we describe lionessR, an R implementation of LIONESS that can be applied to any network reconstruction method in R that outputs a complete, weighted adjacency matrix. As an example, we use lionessR to model single-sample co-expression networks on a bone cancer dataset, and show how lionessR can be used to identify differential co-expression between two groups of patients.\n\nAvailability and implementationThe lionessR open source R package, which includes a vignette of the application, is freely available at https://github.com/mararie/lionessR.\n\nContactmarieke.kuijjer@ncmm.uio.no

bioinformatics↗

Nongenic cancer-risk SNPs affect oncogenes, tumor suppressor genes, and immune function

Genome-wide associations studies (GWASes) have identified many germline genetic variants that are associated with an increased risk of developing cancer. However, how these single nucleotide polymorphisms (SNPs) alter biological function in a way that increases cancer risk is still largely unknown. We used a systems biology approach to analyze the regulatory role and functional associations of cancer-risk SNPs in thirteen distinct tissues. Using data from the Genotype-Tissue Expression (GTEx) project, we performed an expression quantitative trait locus (eQTL) analysis, keeping both cis- and trans-eQTLs, and representing those significant associations as edges in tissue-specific eQTL bipartite networks. We find that each network is organized into highly modular communities that group sets of SNPs together with functionally-related collections of genes. We mapped cancer-risk SNPs to each tissue-specific eQTL network. Although we find in each tissue that cancer-risk SNPs are distributed across the network, they are not uniformly distributed. Rather they are significantly over-represented in a small number of communities. This includes communities enriched for immune response processes as well as communities representing tissue-specific functions. Moreover, cancer-risk SNPs are over-represented in the central \"cores\" of communities, meaning they are more likely to influence the expression of many genes within the same community, thus affecting biological processes. And finally, we find that cancer-risk SNPs preferentially target oncogenes and tumor suppressor genes, suggesting non-genic mutations may still alter the effects of these key cancer-associated genes. This bipartite eQTL network approach provides a new way of understanding genetic effects on cancer risk and provides a biological context for interpreting the results of GWAS cancer studies.

cancer biology↗

Gene regulatory network analysis identifies sex-linked differences in colon cancer drug metabolism processes

Significant sex differences are observed in colon cancer, and understanding these differences is essential to advance disease prevention, diagnosis, and treatment. Males have a higher risk of developing colon cancer and a lower survival rate than women. However, the molecular features that drive these sex differences are poorly understood. We used both transcript-based and gene regulatory network methods to analyze RNA-Seq data from The Cancer Genome Atlas for 445 patients with colon cancer. We compared gene expression between tumors in men and women and found no significant sex differences except for sex-chromosome genes. We then inferred patient-specific gene regulatory networks, and found significant regulatory differences between males and females, with drug and xenobiotics metabolism via cytochrome P450 pathways more strongly targeted in females. This finding was validated in a dataset that included 1,193 patients from five independent studies. While targeting of the drug metabolism pathway did not change the overall survival for males treated with adjuvant chemotherapy, females with greater targeting had an increase in 10-year overall survival probability, with 89% (95% CI: 78%-100%) survival compared to 61% (95% CI: 45%-82%) for women with lower targeting, respectively (p=0.034). Our network analysis uncovered patterns of transcriptional regulation that differentiate male and female colon cancer. Most importantly, targeting of the drug metabolism pathway was predictive of survival in women who received adjuvant chemotherapy. This network-based approach can be used to investigate the molecular features that drive sex differences in other cancers and complex diseases.

systems biology↗

Cancer subtype identification using somatic mutation data

BACKGROUNDWith the onset of next generation sequencing technologies, we have made great progress in identifying recurrent mutational drivers of cancer. As cancer tissues are now frequently screened for specific sets of mutations, a large amount of samples has become available for analysis. Classification of patients with similar mutation profiles may help identifying subgroups of patients who might benefit from specific types of treatment. However, classification based on somatic mutations is challenging due to the sparseness and heterogeneity of the data.\n\nMETHODSHere, we describe a new method to de-sparsify somatic mutation data using biological pathways. We applied this method to 23 cancer types from The Cancer Genome Atlas, including samples from 5, 805 primary tumors.\n\nRESULTSWe show that, for most cancer types, de-sparsified mutation data associates with phenotypic data. We identify poor prognostic subtypes in three cancer types, which are associated with mutations in signal transduction pathways for which targeted treatment options are available. We identify subtype-drug associations for 14 additional subtypes. Finally, we perform a pan-cancer subtyping analysis and identify nine pan-cancer subtypes, which associate with mutations in four overarching sets of biological pathways.\n\nCONCLUSIONSThis study is an important step towards understanding mutational patterns in cancer.

genomics↗

Understanding Tissue-specific Gene Regulation

Although all human tissues carry out common processes, tissues are distinguished by gene expres-sion patterns, implying that distinct regulatory programs control tissue-specificity. In this study, we investigate gene expression and regulation across 38 tissues profiled in the Genotype-Tissue Expression project. We find that network edges (transcription factor to target gene connections) have higher tissue-specificity than network nodes (genes) and that regulating nodes (transcription factors) are less likely to be expressed in a tissue-specific manner as compared to their targets (genes). Gene set enrichment analysis of network targeting also indicates that regulation of tissue-specific function is largely independent of transcription factor expression. In addition, tissue-specific genes are not highly targeted in their corresponding tissue-network. However, they do assume bottleneck positions due to variability in transcription factor targeting and the influence of non-canonical regulatory interactions. These results suggest that tissue-specificity is driven by context-dependent regulatory paths, providing transcriptional control of tissue-specific processes.

genomics↗

A network-based approach to eQTL interpretation and SNP functional characterization

Expression quantitative trait locus (eQTL) analysis associates genotype with gene expression, but most eQTL studies only include cis-acting variants and generally examine a single tissue. We used data from 13 tissues obtained by the Genotype-Tissue Expression (GTEx) project v6.0 and, in each tissue, identified both cis- and trans-eQTLs. For each tissue, we represented significant associations between single nucleotide polymorphisms (SNPs) and genes as edges in a bipartite network. These networks are organized into dense, highly modular communities often representing coherent biological processes. Global network hubs are enriched in distal gene regulatory regions such as enhancers, but are devoid of disease-associated SNPs from genome wide association studies. In contrast, local, community-specific network hubs (core SNPs) are preferentially located in regulatory regions such as promoters and enhancers and highly enriched for trait and disease associations. These results provide help explain how many weak-effect SNPs might together influence cellular function and phenotype.

genomics↗

Tissue-aware RNA-Seq processing and normalization for heterogeneous and sparse data

Although ultrahigh-throughput RNA-Sequencing has become the dominant technology for genome-wide transcriptional profiling, the vast majority of RNA-Seq studies typically profile only tens of samples, and most analytical pipelines are optimized for these smaller studies. However, projects are generating ever-larger data sets comprising RNA-Seq data from hundreds or thousands of samples, often collected at multiple centers and from diverse tissues. These complex data sets present significant analytical challenges due to batch and tissue effects, but provide the opportunity to revisit the assumptions and methods that we use to preprocess, normalize, and filter RNA-Seq data - critical first steps for any subsequent analysis. We find analysis of large RNA-Seq data sets requires both careful quality control and that one account for sparsity due to the heterogeneity intrinsic in multi-group studies. An R package instantiating our method for large-scale RNA-Seq normalization and preprocessing, YARN, is available at bioconductor.org/packages/yarn.\n\nHighlightsO_LIOverview of assumptions used in preprocessing and normalization\nC_LIO_LIPipeline for preprocessing, quality control, and normalization of large heterogeneous data\nC_LIO_LIA Bioconductor package for the YARN pipeline and easy manipulation of count data\nC_LIO_LIPreprocessed GTEx data set using the YARN pipeline available as a resource\nC_LI

bioinformatics↗

Transcriptional landscape of cell lines and their tissues of origin

Cell lines are an indispensable tool in biomedical research and often used as surrogates for tissues. An important question is how well a cell lines transcriptional and regulatory processes reflect those of its tissue of origin. We analyzed RNA-Seq data from GTEx for 127 paired Epstein-Barr virus transformed lymphoblastoid cell lines and whole blood samples; and 244 paired fibroblast cell lines and skin biopsies. A combination of gene expression and network analyses shows that while cell lines carry the expression signatures of their primary tissues, albeit at reduced levels, they also exhibit changes in their patterns of transcription factor regulation. Cell cycle genes are over-expressed in cell lines compared to primary tissue, and they have a reduction of repressive transcription factor targeting. Our results provide insight into the expression and regulatory alterations observed in cell lines and suggest that these changes should be considered when using cell lines as models.\n\nHighlightsO_LICell lines differ from their source tissues in gene expression and regulation\nC_LIO_LIDistinct cell lines share altered patterns of cell cycle regulation\nC_LIO_LICell cycle genes are less strongly targeted by repressive TFs in cell lines\nC_LIO_LICell lines share expression with their source tissue, but at reduced levels\nC_LI

genomics↗

Sexual dimorphism in gene expression and regulatory networks across human tissues

Sexual dimorphism manifests in many diseases and may drive sex-specific therapeutic responses. To understand the molecular basis of sexual dimorphism, we conducted a comprehensive assessment of gene expression and regulatory network modeling in 31 tissues using 8716 human transcriptomes from GTEx. We observed sexually dimorphic patterns of gene expression involving as many as 60% of autosomal genes, depending on the tissue. Interestingly, sex hormone receptors do not exhibit sexually dimorphic expression in most tissues; however, differential network targeting by hormone receptors and other transcription factors (TFs) captures their downstream sexually dimorphic gene expression. Furthermore, differential network wiring was found extensively in several tissues, particularly in brain, in which not all regions exhibit strong differential expression. This systems-based analysis provides a new perspective on the drivers of sexual dimorphism, one in which a repertoire of TFs plays important roles in sex-specific rewiring of gene regulatory networks.\n\nHighlightsO_LISexual dimorphism manifests in both gene expression and gene regulatory networks\nC_LIO_LISubstantial sexual dimorphism in regulatory networks was found in several tissues\nC_LIO_LIMany differentially regulated genes are not differentially expressed\nC_LIO_LISex hormone receptors do not exhibit sexually dimorphic expression in most tissues\nC_LI

genomics↗